| pubmed-article:3159938 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:3159938 | lifeskim:mentions | umls-concept:C0032105 | lld:lifeskim |
| pubmed-article:3159938 | lifeskim:mentions | umls-concept:C0238767 | lld:lifeskim |
| pubmed-article:3159938 | lifeskim:mentions | umls-concept:C0002844 | lld:lifeskim |
| pubmed-article:3159938 | lifeskim:mentions | umls-concept:C0266361 | lld:lifeskim |
| pubmed-article:3159938 | lifeskim:mentions | umls-concept:C0024153 | lld:lifeskim |
| pubmed-article:3159938 | lifeskim:mentions | umls-concept:C1533148 | lld:lifeskim |
| pubmed-article:3159938 | pubmed:issue | 5 | lld:pubmed |
| pubmed-article:3159938 | pubmed:dateCreated | 1985-8-5 | lld:pubmed |
| pubmed-article:3159938 | pubmed:abstractText | A true hermaphrodite with a bilateral ovotestis and a 46 XX karyotype was studied. This 14-year old subject developed ambiguous puberty with bilateral gynecomastia and stage IV public hair. Relatively high level of testosterone (T) (2.80 ng/ml), was found. The 5 alpha-reductase activity for T in the pubic skin was similar to that observed in normal adult males. A hemorrhagic corpus luteum in the left ovotestis was observed at laparotomy. The luteal phase immediately after dexamethasone administration (1 mg/day for 7 days) was characterized by a significant decrease of plasma androgens, T and androstenedione (A). The constantly low level of T (0.30 ng/ml) during the luteal phase in this subject did not appear to be due to the previously administered dexamethasone. This decrease of T production in the luteal phase might be secondary either to the increase of the estradiol-17 beta (E2) secreted by the corpus luteum or to the decrease of LH levels. Both mechanisms might act concomitantly. | lld:pubmed |
| pubmed-article:3159938 | pubmed:language | eng | lld:pubmed |
| pubmed-article:3159938 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:3159938 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:3159938 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:3159938 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:3159938 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:3159938 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:3159938 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:3159938 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:3159938 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:3159938 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:3159938 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:3159938 | pubmed:month | May | lld:pubmed |
| pubmed-article:3159938 | pubmed:issn | 0022-4731 | lld:pubmed |
| pubmed-article:3159938 | pubmed:author | pubmed-author:BercoviciJ... | lld:pubmed |
| pubmed-article:3159938 | pubmed:author | pubmed-author:NahoulKK | lld:pubmed |
| pubmed-article:3159938 | pubmed:author | pubmed-author:SchollerRR | lld:pubmed |
| pubmed-article:3159938 | pubmed:author | pubmed-author:MaudelondeTT | lld:pubmed |
| pubmed-article:3159938 | pubmed:author | pubmed-author:TaterDD | lld:pubmed |
| pubmed-article:3159938 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:3159938 | pubmed:volume | 22 | lld:pubmed |
| pubmed-article:3159938 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:3159938 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:3159938 | pubmed:pagination | 631-4 | lld:pubmed |
| pubmed-article:3159938 | pubmed:dateRevised | 2010-11-18 | lld:pubmed |
| pubmed-article:3159938 | pubmed:meshHeading | pubmed-meshheading:3159938-... | lld:pubmed |
| pubmed-article:3159938 | pubmed:meshHeading | pubmed-meshheading:3159938-... | lld:pubmed |
| pubmed-article:3159938 | pubmed:meshHeading | pubmed-meshheading:3159938-... | lld:pubmed |
| pubmed-article:3159938 | pubmed:meshHeading | pubmed-meshheading:3159938-... | lld:pubmed |
| pubmed-article:3159938 | pubmed:meshHeading | pubmed-meshheading:3159938-... | lld:pubmed |
| pubmed-article:3159938 | pubmed:meshHeading | pubmed-meshheading:3159938-... | lld:pubmed |
| pubmed-article:3159938 | pubmed:meshHeading | pubmed-meshheading:3159938-... | lld:pubmed |
| pubmed-article:3159938 | pubmed:meshHeading | pubmed-meshheading:3159938-... | lld:pubmed |
| pubmed-article:3159938 | pubmed:meshHeading | pubmed-meshheading:3159938-... | lld:pubmed |
| pubmed-article:3159938 | pubmed:meshHeading | pubmed-meshheading:3159938-... | lld:pubmed |
| pubmed-article:3159938 | pubmed:meshHeading | pubmed-meshheading:3159938-... | lld:pubmed |
| pubmed-article:3159938 | pubmed:meshHeading | pubmed-meshheading:3159938-... | lld:pubmed |
| pubmed-article:3159938 | pubmed:meshHeading | pubmed-meshheading:3159938-... | lld:pubmed |
| pubmed-article:3159938 | pubmed:meshHeading | pubmed-meshheading:3159938-... | lld:pubmed |
| pubmed-article:3159938 | pubmed:meshHeading | pubmed-meshheading:3159938-... | lld:pubmed |
| pubmed-article:3159938 | pubmed:meshHeading | pubmed-meshheading:3159938-... | lld:pubmed |
| pubmed-article:3159938 | pubmed:meshHeading | pubmed-meshheading:3159938-... | lld:pubmed |
| pubmed-article:3159938 | pubmed:meshHeading | pubmed-meshheading:3159938-... | lld:pubmed |
| pubmed-article:3159938 | pubmed:meshHeading | pubmed-meshheading:3159938-... | lld:pubmed |
| pubmed-article:3159938 | pubmed:year | 1985 | lld:pubmed |
| pubmed-article:3159938 | pubmed:articleTitle | Plasma androgens during the luteal phase in a case of true hermaphroditism with bilateral ovotestis. | lld:pubmed |
| pubmed-article:3159938 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:3159938 | pubmed:publicationType | In Vitro | lld:pubmed |
| pubmed-article:3159938 | pubmed:publicationType | Case Reports | lld:pubmed |
